scispace - formally typeset
C

Claudio Graiff

Publications -  28
Citations -  696

Claudio Graiff is an academic researcher. The author has contributed to research in topics: Breast cancer & Radiation therapy. The author has an hindex of 12, co-authored 28 publications receiving 567 citations.

Papers
More filters
Journal ArticleDOI

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Marco Colleoni, +252 more
- 01 Jan 2018 - 
TL;DR: Extended intermittent use of adjuvant letrozole in postmenopausal women with hormone receptor-positive, lymph node- positive, and operable breast cancer for which they had undergone local treatment and had completed 4-6 years of adjUvant endocrine therapy is hypothesised to improve breast cancer outcome compared with continuous use of letroZole.
Journal ArticleDOI

Complete response after treatment with imatinib in pretreated disseminated testicular seminoma with overexpression of c-KIT.

TL;DR: The case of a 39-year-old man with disseminated testicular seminoma that was refractory to salvage chemotherapy, and who had complete remission after imatinib administration is described.
Journal ArticleDOI

Cisplatin, hyperthermia, and radiation (trimodal therapy) in patients with locally advanced head and neck tumors: A phase I–II study

TL;DR: The study confirms the feasibility of the combination of cisplatin, heat, and radiation with an acceptable toxicity profile in the treatment of superficial cervical nodal metastases from head and neck cancer and the trimodal therapy deserves further evaluation.
Journal ArticleDOI

Phase II study of estramustine, oral etoposide, and vinorelbine in hormone-refractory prostate cancer

TL;DR: The results of this study indicate that the schedule of estramustine associated with vinorelbine is active and well tolerated in hormone-refractory prostate cancer patients.